CELC vs. CDNA, FLGT, CSTL, SERA, BDSX, VRDN, ENZ, RNLX, XGN, and DMTK Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include CareDx (CDNA), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Sera Prognostics (SERA), Biodesix (BDSX), Viridian Therapeutics (VRDN), Enzo Biochem (ENZ), Renalytix (RNLX), Exagen (XGN), and DermTech (DMTK). These companies are all part of the "medical laboratories" industry.
Celcuity (NASDAQ:CELC ) and CareDx (NASDAQ:CDNA ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.
Celcuity presently has a consensus target price of $29.50, suggesting a potential upside of 76.12%. CareDx has a consensus target price of $16.50, suggesting a potential upside of 5.91%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than CareDx.
Celcuity has a net margin of 0.00% compared to CareDx's net margin of -66.59%. CareDx's return on equity of -55.08% beat Celcuity's return on equity.
Celcuity has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, CareDx has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500.
In the previous week, Celcuity had 2 more articles in the media than CareDx. MarketBeat recorded 26 mentions for Celcuity and 24 mentions for CareDx. CareDx's average media sentiment score of 0.32 beat Celcuity's score of 0.23 indicating that CareDx is being referred to more favorably in the news media.
CareDx received 101 more outperform votes than Celcuity when rated by MarketBeat users. However, 66.87% of users gave Celcuity an outperform vote while only 66.67% of users gave CareDx an outperform vote.
63.3% of Celcuity shares are held by institutional investors. 20.3% of Celcuity shares are held by insiders. Comparatively, 4.2% of CareDx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Celcuity has higher earnings, but lower revenue than CareDx. Celcuity is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.
Summary Celcuity beats CareDx on 10 of the 17 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Celcuity Competitors List
Related Companies and Tools
